UAE positions itself as a regional leader and a clinical trial hub
The UAE is emerging as a hub for clinical trials with robust infrastructure and regulatory efficiency.
The Evolution of a Global Clinical Trial Hub
The UAE is quickly advancing its precision medicine and genomics capabilities, establishing itself as a major emerging global clinical trial hub, said Adel Aziziyeh, Head of Clinical Operations at IROS, a UAE-based contract research organisation (CRO) at a recent conference. Adel Aziziyeh discussed the UAE’s role as an emerging hub for clinical trials at OCT & CTS meeting in Seoul, South Korea.
To reach these goals, the region focuses on the following core sectors:
- Clinical Trials
- Approvals
- Operations
- Outsourced Services
- Supply Chain
- Data Management
- Medical Devices
Strategic Capabilities and Regulatory Framework
The development of the region is supported by a focus on Artificial Intelligence, Cloud technology, and Corporate Governance. Furthermore, the industry prioritizes social responsibility and environmental sustainability to maintain clinical excellence.
The following table highlights the key reports and insights available for the United Arab Emirates healthcare landscape:
| Resource Type | Focus Area |
|---|---|
| Reports | United Arab Emirates (UAE) Healthcare (Pharma and Medical Devices) |
| Reports | United Arab Emirates (UAE) Healthcare, Regulatory and Reimbursement |
| Data Insights | The gold standard of business intelligence |
Advancing Precision Medicine
Through the integration of precision medicine and genomics capabilities, the UAE continues to position itself as a regional leader. This is supported by the CRO fueled by agility, providing community-based research for better reach, retention and results. To further inform industry stakeholders, guides such as the Leading Guide to Services for the Clinical Trials Industry provide detailed information on manufacturers and suppliers.